Daniel Y. C. Heng, Wanling Xie, Georg A. Bjarnason, Ulka Vaishampayan, Min-Han Tan, Jennifer Knox, Frede Donskov, Lori Wood, Christian Kollmannsberger, Brian I. Rini and Toni K. Choueiri Progression-free survival as a predictor of overall survival in metastatic renal cell carcinoma treated with contemporary targeted therapy Cancer 117
Version of Record online: 18 NOV 2010 | DOI: 10.1002/cncr.25750
Progression at 3 months and 6 months was an independent predictor of overall survival in patients with metastatic renal cell carcinoma. In addition, there was a statistically significant, dependent correlation between progression-free survival and overall survival.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field